ワクチン・ブック(第2版)<br>The Vaccine Book (2ND)

個数:
電子版価格
¥16,171
  • 電子版あり

ワクチン・ブック(第2版)
The Vaccine Book (2ND)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 664 p.
  • 言語 ENG
  • 商品コード 9780128021743
  • DDC分類 614.44

Full Description

The Vaccine Book, Second Edition provides comprehensive information on the current and future state of vaccines. It reveals the scientific opportunities and potential impact of vaccines, including economic and ethical challenges, problems encountered when producing vaccines, how clinical vaccine trials are designed, and how to introduce vaccines into widespread use.

Although vaccines are now available for many diseases, there are still challenges ahead for major diseases, such as AIDS, tuberculosis, and malaria. This book is designed for students, researchers, public health officials, and all others interested in increasing their understanding of vaccines. It answers common questions regarding the use of vaccines in the context of a rapidly expanding anti-vaccine environment.

This new edition is completely updated and revised with new and unique topics, including new vaccines, problems of declining immunization rates, trust in vaccines, the vaccine hesitancy, and the social value of vaccines for the community vs. the individual child's risk.

Contents

Part I: Understanding Vaccine Impact at Population and Individual Levels
1. The Impact of Vaccination on the Epidemiology of Infectious Diseases
2. How Vaccines Work

Part II: How to Design, Assess and Produce Vaccines
3. Vaccine Design in the 21st Century
4. Vaccine Adjuvants
5. Vaccine Production: Main Steps and Considerations
6. How are Vaccines Assessed in Clinical Trials?
7. Immunological Correlates of Vaccine-Mediated Protection

Part III: Vaccine Safety
8. How Vaccine Safety is Monitored
9. Vaccination and Autoimmune Diseases

Part IV: New Vaccination Strategies
10. Maternal Immunization: Protecting Vulnerable Populations
11. New Challenges for Pertussis Vaccines

Part V: Recently Introduced Vaccines
12. Pneumococcus, Pneumococcal Disease, and Prevention
13. Human Papillomavirus Vaccines
14. Rotavirus Vaccines

Part VI: New Approaches for Needed Vaccines
15. Antiviral Vaccines: Challenges and Advances
16. New Approaches for Needed Vaccines: Bacteria
17. Vaccines Against Parasites

Part VII: Major Global Vaccine Challenges
18. Tuberculosis Vaccines
19. Major Global Vaccine Challenges: Recent Progress in Malaria Vaccine Development
20. AIDS Vaccines
21. Influenza Vaccines and Vaccination Strategies

Part VIII: Ethical Considerations
22. Ethical Considerations in Vaccine Trials in Resource-Limited Settings

Part IX: Vaccine Economics
23. Economic Considerations for the Development of Global Vaccines: a Perspective From the Vaccine Industry
24. Introduction of Vaccines Into National Programs
25. Transitioning Immunization Into the Health Care System: Strengthening Routine Immunization in India

Part X: Trust in Vaccines
26. Vaccine Acceptance
27. Trust and Confidence in Vaccines: Tales of Three Vaccines, Lessons for Others

Part XI: Future Challenges
28. Vaccines for Emerging Viral Diseases
29. Cancer Immunotherapy by Checkpoint Blockade
30. Adoptive Cellular Therapy With Synthetic T Cells as an "Instant Vaccine” for Cancer and Immunity

最近チェックした商品